Evidence map›Paper›PMID 40801038›Full record

ArticleFrontiers in endocrinology2025

Epidemiology and temporal trends of childhood type 1 diabetes in China: an analysis of the GBD 2021.

Feng Jin, Limin Xie, Guocheng Wang, Yu Pan, Cuijia Wang, Wei Li

Abstract read
In one paragraph

Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Trial
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Feng JinDepartment of Genetics and Reproductive Medicine, Shunyi Maternal and Children's Hospital of Beijing Children's Hospital, Beijing, China.
Limin XieDepartment of Genetics and Reproductive Medicine, Shunyi Maternal and Children's Hospital of Beijing Children's Hospital, Beijing, China.
Guocheng WangDepartment of Genetics and Reproductive Medicine, Shunyi Maternal and Children's Hospital of Beijing Children's Hospital, Beijing, China.
Yu PanDepartment of Genetics and Reproductive Medicine, Shunyi Maternal and Children's Hospital of Beijing Children's Hospital, Beijing, China.
Cuijia WangDepartment of Genetics and Reproductive Medicine, Shunyi Maternal and Children's Hospital of Beijing Children's Hospital, Beijing, China.
Wei LiBeijing Key Laboratory for Genetics of Birth Defects, Beijing Pediatric Research Institute, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: This study investigates the epidemiological trends of childhood type 1 diabetes (T1D) in China and establishes predictive models to estimate future disease burden. Methods: Temporal trend analyses were performed using data from the Global Burden of Disease (GBD) database, stratified by age and sex. Joinpoint regression analysis was applied to evaluate changes in incidence and mortality rates from 1990 to 2021, complemented by autoregressive integrated moving average (ARIMA) and exponential smoothing state space (ETS) models to project disease trends through 2040. Results: The results indicate a rising trend in the incidence of childhood T1D among Chinese children aged 0-14 years, alongside an overall decline in mortality, reflecting an epidemiological pattern characterized by low incidence yet non-negligible mortality. Notably, infants < 1 year of age have shown increasing mortality rates in recent years. Projections indicate that both incidence and mortality in this age group will continue to increase through 2040. Additionally, incidence among children 1 year of age also expected to persist on an upward trajectory. Sex-based disparities were evident, with girls bearing a higher disease burden than boys, as indicated by elevated incidence, mortality and underdiagnosis rates. Conclusion: These findings necessitate enhanced public health and clinical management strategies for childhood T1D in China, specifically targeting underdiagnosis reduction, incidence rate stabilization, and mortality rate improvement.

Indexed as

Diabetes Mellitus, Type 1AdolescentChildChild, PreschoolChinaFemaleGlobal Burden of DiseaseHumansIncidenceInfantInfant, NewbornMalechildhood diabetesChinaGBDT1Dtemporal trends

Identifiers

PMID40801038
PMCPMC12339348

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.